Eph tumour suppression: the dark side of Gleevec
- 1 August 2006
- journal article
- Published by Springer Science and Business Media LLC in Nature
- Vol. 8 (8), 785-786
- https://doi.org/10.1038/ncb0806-785
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl–Crk pathwayNature, 2006
- EphB Receptors Coordinate Migration and Proliferation in the Intestinal Stem Cell NicheCell, 2006
- EphB/EphrinB Receptors and Wnt Signaling in Colorectal CancerCancer Research, 2006
- A conditional feedback loop regulates Ras activity through EphA2Cancer Cell, 2005
- Eph receptor signalling casts a wide net on cell behaviourNature Reviews Molecular Cell Biology, 2005
- The development of imatinib as a therapeutic agent for chronic myeloid leukemiaBlood, 2005
- Nucleo-cytoplasmic communication in apoptotic response to genotoxic and inflammatory stressCell Research, 2005
- Controlling Abl: auto-inhibition and co-inhibition?Nature, 2004
- c-Abl is an effector of Src for growth factor-induced c-myc expression and DNA synthesisThe EMBO Journal, 2002
- Inhibition of Cell Migration by Abl Family Tyrosine Kinases through Uncoupling of Crk-CAS ComplexesPublished by Elsevier BV ,2001